In vitro Intestinal Epithelial Wound-healing Assays Using Electric Cell-Substrate Impedance Sensing Instrument    

Materials and Reagents

1. 75 cm² Tissue culture flasks (Greiner Bio-One, catalog number: 658170)
2. 2- and 10-ml plastic pipettes (Sigma-Aldrich, catalog number: CLS4101)
3. Pipet Tip, Pipetman, PK1000 (Grainger, catalog number: 52jy20)
   
4. Invitrogen^TM Countess^TM Cell Counting Chamber Slides (Thermo Fisher Scientific, Invitrogen, catalog number: C10312)
5. Epithelial cell line Caco2-BBE or C2BBe1 (ATCC, catalog number: ATCC^® HTB-37^TM)
6. DMEM (1:1) 1x medium (Thermo Fisher Scientific, Gibco, catalog number: 12634010)
7. Fetal Bovine Serum (FBS) Premium Heat Inactivated at 56 °C (Atlanta Biologicals, catalog number: S11050H)
8. Penicillin-Streptomycin (Pen/Strep) (Thermo Fisher Scientific, Gibco, catalog number: 15140122)
9. Phosphate Buffered Saline (PBS 1x) (Thermo Fisher Scientific, Gibco, catalog number: 10010049)
10. 0.25% Trypsin-EDTA (1x) (Thermo Fisher Scientific, Gibco, catalog number: 25200056)
11. Invitrogen^TM Trypan Blue Stain (0.4%) (Thermo Fisher Scientific, Invitrogen, catalog number: T10282)
12. Recombinant Human IL-22 Protein (R&D Systems, catalog number: 782-IL10)
13. Cell culture medium (see Recipes)
14. IL22 stock (see Recipes)
    

Equipment

1. PIPETMAN Classic P1000 (Gilson, catalog number: FA10006M)
2. Drummond Scientific Pipet-Aid^® Portable XP w/110 V recharger (Drummond Scientific, catalog number: 4-000-100)
3. Laminar Flow Hood (LabGard Class II type A2 Biological Safety Cabinet, Nuaire, model: NU-540)
4. Thermo Scientific 3110 CO₂ Water Jacketed Incubator (Thermo Fisher Scientific, model: 4120)
5. Digital Water Bath (VWR, catalog number: 89501-460)
6. Nikon Eclipse TS100 inverted microscope (Nikon, model: Eclipse TS100)
7. Countess^TM automated cell counter (Thermo Fisher Scientific, Invitrogen, catalog number: AMQAF1000)
8. ECIS Zθ (Theta and 16 W array station (Applied Bio Physics, https://www.biophysics.com/products.php) (Figure 1)
9. CO₂ Compact Tissue Culture Incubator (Shel Lab, Model SCO5A) (Figure 1)
10. 8W10E+ Cultureware (Ibidi, catalog number: 72001) (Figure 2)
11. OptiPlex 7760 All-in-One (6 Cores/9MB/6T/up to 4.1GHz/65W) (Dell)
    
    
    Figure 1. ECIA Zq (Theta) and 16 W array station (inside the CO₂ Compact tissue culture incubator)
    
    
    Figure 2. 8 Well arrays “8W1E”. Each of the 8 wells contains a single circular 250 μm diameter active electrode (dot at the end of the blue arrow). Each well has a substrate area of 0.8 cm² and a maximum volume of 500 μl.
    

Software

1. ECIS Z software (https://www.biophysics.com/products-ecisz0.php)
2. Microsoft Office Excel (Microsoft)
   

Procedure

1. Caco-2-BBE cells are routinely maintained in tissue culture flasks in Dulbecco’s Modified Eagle Medium (DMEM) medium containing 10% Inactivated Fetal Bovine Serum (FBS) and 1% penicillin-streptomycin and are put into a cell incubator set at 37 °C, in 5% CO₂, and 90% humidity.
2. Observe confluency of Caco2-BBE cells in a 75 cm² flask under the inverted microscope (Nikon Eclipse TS100) (Figure 3).
   
   
   Figure 3. Micrograpic image of confluent Caco2-BBE monolayers in 75 cm² flasks. Magnification: 10x.
   
   
3. Under a laminar flow hood, rinse the 75 cm² flask containing Caco2-BBE cells with PBS 1x (3 times each time with 5 ml PBS).
4. Add 2 ml of 0.25% Trypsin-EDTA.
5. Put the 75 cm² flask containing Caco2-BBE cells with 2 ml of 0.25% Trypsin-EDTA into the cell incubator for 5 min.
6. Observe cell dissociation under the inverted microscope (Nikon Eclipse TS100). 
7. If well dissociated, add 10 ml of DMEM supplemented with 10% FBS and 1% P/S media into the flask to inactivate trypsin and thoroughly pipette up and down (using 2 ml plastic pipettes) to break the cell clumps.
8. Place the 75 cm² flask containing Caco2-BBE cells under the inverted microscope (Nikon Eclipse TS100) and observe that Caco2-BBE cells are a single cell suspension (no cell clumps). If not go back to Step 7.
9. Count the cells using Invitrogen Countess^TM automated counter. The Countess^TM automated cell counter is a benchtop counter designed to measure cell count and viability (live, dead, and total cells) accurately and precisely, using the standard trypan blue technique.
10. Plate Caco2-BBE cells at 0.3 x 10⁶ cells per well into two 8W10E+ Cultureware arrays with culture medium volume of 500 μl/well (one array contains 8 wells). 
11. The 2 Culturewares (16 wells) in the ECIS array station allow the observer to design experiments with duplicates/triplicates with the appropriate controls. 
12. Put the 2 Culturewares in the ECIS array containing Caco2-BBE cells within the incubator station (see Figure 4) and close the incubator door. Incubator is set at 37 °C, in 5% CO₂ and 90% humidity.
    
    
    Figure 4. Two Culturewares in the ECIS array station within the incubator
    
    
13. Chose “8W10E” as well configuration.
14. Click the “Set up” button to verify that arrays are properly connected to the system (Figure 5). 
    
    
    Figure 5. ECIS software and set-up procedure to measure epithelial electrical resistance (R). Select “8W1E” as well arrays (1), select all wells in “Holder A and Holder B” (1), click the “Setup” button (2) to check if arrays are properly connected to the system. Wells that are connected to the system show a green color (1). Select “Single Freq.” (3) as 500 Hz (4) and click “Start” (5) and specify where the data are stored. Experiment commments may be documented (6).
    
    
15. Wells that are connected to the system show a green color (Figure 5). Wells not connected to the system show a red color. If the array diagram shows red, adjust the position of the Cultureware slightly and click “Check” to make sure that each well of the Cultureware is connected properly to the system.
16. Select “The well to measure”.
17. Select “Single frequency” (For Caco2-BBE, the optimal single frequency is 500 Hz) (Charrier et al., 2005) (Figure 5).
18. Interval (sec): uncheck. (maximum data acquisition) (Figure 5).
19. Click “Start” and specify where the data are stored (Figure 5).
20. When Caco2-BBE reach confluency after 20-30 h growth (Resistance plateau) check “Wound/electroporation Setup” (Figure 6). 
21. Select the “Wells to wound” in the “Well Configuration” (Figure 6).
22. Select “Wound time” (30 s [Figure 6], optimal for Caco2-BBE) (Charrier et al., 2005; Zhang et al., 2016; Xiao et al., 2018).
23. Select “Wound Current” (1,400 μA [Figure 6], optimal for Caco2-BBE) (Charrier et al., 2005; Zhang et al., 2016; Xiao et al., 2018).
24. Select “Frequency” (40k Hz [Figure 6], optimal for Caco2-BBE) (Charrier et al., 2005; Zhang et al., 2016; Xiao et al., 2018).
25. Click “Activate” (Figure 6).
    
    
    Figure 6. Wound to Caco-2-BBE monolayers. Select the “wells to wound” in the “Well Configuration” (1), select “Wound/Electroporate Setup” (2), select “Wound” (3), select “30 sec” as “Wound Time” (4), select “1400 μA” as “Wound Current” (5), select “40k Hz” as “Frequency” (6) and click “Activate” (7).
    
    
26. After wound infliction, verify that the R value drop to a value close to an electrode without cells. If that is not the case, repeat the wounding.
27. After the application of wound to the epithelium, treatments (drug-addition) may be applied to designated wells in order to assess the pro-healing or the anti-healing of the added drug. 
28. When the healing is done, R return to the resistance value before the wound, stop the experiment by click “Finish” (Figure 7). 
29. Go to file and select “Export data” (Figure 7).
    
    
    Figure 7. Wound Healing of Caco-2-BBE monolayers. When healing is done, click “Finish” (1), go the “File” (2), select “Export data” (3).
    
    
30. As an example, we have demonstrated (Figure 7 in Xiao et al., 2018) that wounded epithelial layers treated with IL-22 (0, 50 and 100 ng/ml as final concentration) showed significant and dose-dependent increase in recovery, in comparison with untreated wounded epithelial layers. These results clearly demonstrate that IL-22 can enhance the healing of a wounded colonic epithelial layer. In another study (Figure 6 in Charrier et al., 2005), we have demonstrated that after the wound, the resistance of Caco2-BBE/ADAM-15 cells (Caco2-BBE over-expressing ADAM-15) did not increase to reach the resistance values of the non-wounded cells (Figure 6A in Charrier et al., 2005). By contrast, the resistance of Caco2-BBE/Vect cells (endogenous ADAM-15 expression in Caco2-BBE) increased over time and reached the resistance values of the non-wounded cells (Figure 6A in Charrier et al., 2005). These results are in correlation with the observations made at the end of the experiments where the wounds were completely healed in Caco2-BBE/Vect cells but were unable to heal in Caco2-BBE/ADAM-15 cells (Figure 6B in Charrier et al., 2005).

Data analysis

1. Go to “File” (Figure 7), click on “Export data” (Figure 7), select “All data” or “Selected wells/time” (Figure 6), select “To excel” or “Graph data” (Figure 7).
2. Use the data in excel for statistical analysis and create the experiment graph.
   

Recipes

1. Cell culture medium
   Dulbecco’s Modified Eagle Medium (DMEM) medium containing 10% Inactivated Fetal Bovine Serum (FBS) and 1% penicillin-streptomycin 
2. IL22 stock solution
   10 μg/ml in cell culture medium
   

Acknowledgments

EV is a recipient of the Career Development Award from the Crohn’s and Colitis Foundation. This protocol was adapted from published work by Charrier et al. (2005), Zhang et al. (2016) and Xiao et al. (2018).

Competing interests

The authors declare no conflicts of interest within this work.

References

1. Charrier, L., Yan, Y., Driss, A., Laboisse, C. L., Sitaraman, S. V. and Merlin, D. (2005). ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers. Am J Physiol Gastrointest Liver Physiol 288(2): G346-353.
2. Xiao, B., Chen, Q., Zhang, Z., Wang, L., Kang, Y., Denning, T. and Merlin, D. (2018). TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis. J Control Release 287:235-246.
3. Zhang, M., Viennois, E., Prasad, M., Zhang, Y., Wang, L., Zhang, Z., Han, M. K., Xiao, B., Xu, C., Srinivasan, S. and Merlin, D. (2016). Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials 101: 321-340.